Green Thumb Industries (GTBIF) Other Non-Current Assets (2019 - 2026)

Green Thumb Industries (GTBIF) posted Other Non-Current Assets of $4.4 million for Q1 2026, up 111.25% on a QoQ basis from $2.1 million in Q4 2025, and up 1.63% year-over-year from $4.4 million in Q1 2025.

Green Thumb Industries (GTBIF) Other Non-Current Assets (2019 - 2026) Analysis & Trends

Green Thumb Industries' Other Non-Current Assets history runs 8 years deep, the most recent figure standing at $4.4 million for Q1 2026.

  • Quarterly Other Non-Current Assets rose 1.63% year-over-year to $4.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.4 million (up 1.63% YoY) and the FY2025 annual result came in at $2.1 million, down 3.23% from the prior year.
  • Other Non-Current Assets was $4.4 million for Q1 2026 at Green Thumb Industries, up from $2.1 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $4.4 million in Q1 2026 and bottomed at $2.0 million in Q2 2025.
  • A 5-year average of $2.8 million and a median of $2.6 million in 2024 frame the typical range for Other Non-Current Assets.
  • Peak annual rise in Other Non-Current Assets reached 69.54% in 2025, while the deepest fall reached 21.57% in 2025.
  • Green Thumb Industries' Other Non-Current Assets stood at $3.1 million in 2022, then dropped by 16.44% to $2.6 million in 2023, then declined by 15.25% to $2.2 million in 2024, then declined by 3.23% to $2.1 million in 2025, then soared by 111.25% to $4.4 million in 2026.
  • Business Quant data shows GTBIF's Other Non-Current Assets at $4.4 million in Q1 2026, $2.1 million in Q4 2025, and $2.3 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 49.22 Mn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 1.79 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 351.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 491.06 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 233.20 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.11 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 73.60 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 295.00 Mn
10 Green Thumb Industries 1.63 Bn 1.29 Bn 143.65 Mn 4.43 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.43 Mn
Dec 31, 2025 2.10 Mn
Sep 30, 2025 2.29 Mn
Jun 30, 2025 2.01 Mn
Mar 31, 2025 4.36 Mn
Dec 31, 2024 2.17 Mn
Sep 30, 2024 2.51 Mn
Jun 30, 2024 2.57 Mn
Mar 31, 2024 2.57 Mn
Dec 31, 2023 2.56 Mn
Sep 30, 2023 2.53 Mn
Jun 30, 2023 2.38 Mn
Mar 31, 2023 3.22 Mn
Dec 31, 2022 3.06 Mn
Sep 30, 2022 2.66 Mn
Jun 30, 2022 2.79 Mn
Mar 31, 2022 3.04 Mn
Dec 31, 2021 2.64 Mn
Sep 30, 2021 2.87 Mn
Mar 31, 2021 2.26 Mn